Arcturus Therapeutics Holdings Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| SASSINE ANDY | Chief Financial Officer | Purchase | 5,000 | $29.74 | $148,700 | 273,245 | Jun 10, 2020 |
| Ultragenyx Pharmaceutical Inc. | — | Option Exercise | 600,000 | $16.00 | $9,600,000 | 3,000,000 | May 20, 2020 |
| SASSINE ANDY | Chief Financial Officer | Purchase | 5,649 | $9.73 | $54,965 | 268,245 | Dec 5, 2019 |
| SASSINE ANDY | Chief Financial Officer | Purchase | 10,000 | $10.00 | $100,000 | 257,596 | Dec 3, 2019 |
| Marquet Magda | — | Purchase | 2,300 | $10.58 | $24,334 | 22,720 | Sep 13, 2019 |
| Kummerfeld Keith C | See Remarks | Purchase | 500 | $10.69 | $5,345 | 500 | Sep 12, 2019 |
| Payne Joseph E | President and CEO | Purchase | 5,000 | $11.22 | $56,100 | 1,474,097 | Aug 29, 2019 |
| SASSINE ANDY | Chief Financial Officer | Purchase | 10,000 | $10.90 | $109,000 | 247,596 | Aug 23, 2019 |
| FARRELL PETER C | — | Purchase | 4,681 | $11.02 | $51,585 | 38,523 | Aug 20, 2019 |